億利潔能(600277.SH):“武威50萬千瓦光伏治沙”和“蒙西庫布其200萬千瓦光伏治沙” 項目已開工建設
格隆匯3月8日丨億利潔能(600277.SH)發佈股票交易異常波動公吿,公司主營業務分為以氯鹼、聚酯產業為核心的清潔煤化工、清潔熱力及光氫新能源業務,現有氫能源產能為工業副產氫,目前為自產自用。根據中國證監會行業分類,公司所屬化學原料和化學制品製造業,根據公司《2020年年度報吿》披露,光伏發電收入在主營業務收入中佔比 4.64%。截至目前,公司投資的“武威50萬千瓦光伏治沙”和“蒙西庫布其200萬千瓦光伏治沙” 項目已開工建設,尚未產生營業收入。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.